Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PAX | VET |
|---|---|---|
| Price | $11.10 | $11.73 |
| Change today | ▲ 8.72% | ▲ 0.43% |
| Market cap | $1.79B | $1.79B |
| Return, 3 months | +1.7% | +30.6% |
| Return, year to date | -27.3% | +44.1% |
| Return, 1 year | -18.1% | +41.7% |
| P/E (TTM) | 24.9 | -5.8 |
| P/B | 3.2 | 1.2 |
| P/E percentile vs own 5y | 73rd | – |
| Dividend yield | 5.41% | 3.18% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | -0.9% | +14.7% |
| Analyst buy share | 0% | 20% |
| RSI (14) | 62 | 45 |
| 30-day volatility | 35.1% | 36.0% |
| Max drawdown, 1 year | -40.9% | -38.9% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Sell | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
